D.Western Therapeutics Institute, Inc. [4576.T]
TOKYO, May 14 (Pulse News Wire) – D.Western Therapeutics Institute, Inc. (4576.T) completed the subscription process for restricted share awards.
The issuance was approved during the April 17, 2026 board meeting. Details of the issuance are available in the April 17 press release. The restricted shares consist of ordinary shares totaling 501,200. Each share was issued at ¥94 per share, resulting in a total issue amount of ¥47.1 million.
The allotment targets included two directors (excluding audit committee members and outside directors) and 15 employees, along with three directors from subsidiary Nippon Innovation Pharmaceuticals (excluding outside directors). A total of 197,000 shares were allocated. The payment deadline for the subscription was set. For more detailed information, interested parties should refer to the April 17, 2026 press release.
🟢 Confidence: High AI-translated content.